Everolimus more effective than sirolimus in coronary stents
NEW YORK (Reuters Health) - Mortality rates are similar, but pooled data show other advantages when
coronary stents are coated with everolimus rather than sirolimus, researchers say.
Source: Modern Medicine - Category: Journals (General) Source Type: news
More News: General Medicine | Health